Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial
2001 ◽
Vol 27
(10)
◽
pp. 1578-1583
◽
1999 ◽
Vol 27
(Supplement)
◽
pp. 164A
◽
1997 ◽
Vol 12
(4)
◽
pp. 177-182
◽
2017 ◽
Vol 5
(6)
◽
pp. 484-491
◽
2015 ◽
Vol 16
(3)
◽
pp. e74-e81
◽
2008 ◽
Vol 36
(3)
◽
pp. 782-788
◽